Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Epidemiology of prostate cancer and treatment remarks.

Literature DB >> 22778875

Epidemiology of prostate cancer and treatment remarks.

Stefano Arcangeli¹, Valentina Pinzi, Giorgio Arcangeli.

Abstract

Prostate cancer is one of the most common types of cancer and one of the leading causes of cancer death among men in the Western countries. The aim of the present analysis is to assess the cancer burden in order to ensure accurate strategies for chemoprevention and treatment, including the major therapeutic approaches for localized high-risk disease - surgery and radiation therapy - and quality of life issues related to each option.

Entities: Disease Species

Keywords: Chemoprevention; Epidemiology; Prostate cancer; Radiotherapy

Year: 2012 PMID： 22778875 PMCID： PMC3391668 DOI： 10.4329/wjr.v4.i6.241

Source DB: PubMed Journal: World J Radiol ISSN： 1949-8470

37 in total

1. A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months.

Authors: Koichiro Akakura; Hiroyoshi Suzuki; Tomohiko Ichikawa; Hiroyuki Fujimoto; Osamu Maeda; Michiyuki Usami; Daisaku Hirano; Yukie Takimoto; Toshiyuki Kamoto; Osamu Ogawa; Yoshiteru Sumiyoshi; Jun Shimazaki; Tadao Kakizoe
Journal: Jpn J Clin Oncol Date: 2006-11-02 Impact factor: 3.019

2. Effect of dutasteride on the risk of prostate cancer.

Authors: Gerald L Andriole; David G Bostwick; Otis W Brawley; Leonard G Gomella; Michael Marberger; Francesco Montorsi; Curtis A Pettaway; Teuvo L Tammela; Claudio Teloken; Donald J Tindall; Matthew C Somerville; Timothy H Wilson; Ivy L Fowler; Roger S Rittmaster
Journal: N Engl J Med Date: 2010-04-01 Impact factor: 91.245

3. Latent carcinoma and atypical lesions of prostate. An autopsy study.

Authors: A Billis
Journal: Urology Date: 1986-10 Impact factor: 2.649

4. Cancer statistics, 1999.

Authors: S H Landis; T Murray; S Bolden; P A Wingo
Journal: CA Cancer J Clin Date: 1999 Jan-Feb Impact factor: 508.702

Review 5. Prostate cancer prevention: past, present, and future.

Authors: Neil Fleshner; Alexandre R Zlotta
Journal: Cancer Date: 2007-11-01 Impact factor: 6.860

6. Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation.

Authors: C L Hanchette; G G Schwartz
Journal: Cancer Date: 1992-12-15 Impact factor: 6.860

7. Prevalence of latent prostate carcinoma in two U.S. populations.

Authors: J M Guileyardo; W D Johnson; R A Welsh; K Akazaki; P Correa
Journal: J Natl Cancer Inst Date: 1980-08 Impact factor: 13.506

8. Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial.

Authors: J Michael Gaziano; Robert J Glynn; William G Christen; Tobias Kurth; Charlene Belanger; Jean MacFadyen; Vadim Bubes; JoAnn E Manson; Howard D Sesso; Julie E Buring
Journal: JAMA Date: 2008-12-09 Impact factor: 56.272

9. Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter.

Authors: Ian M Thompson; Donna K Pauler; Phyllis J Goodman; Catherine M Tangen; M Scott Lucia; Howard L Parnes; Lori M Minasian; Leslie G Ford; Scott M Lippman; E David Crawford; John J Crowley; Charles A Coltman
Journal: N Engl J Med Date: 2004-05-27 Impact factor: 91.245

10. Detection bias due to the effect of finasteride on prostate volume: a modeling approach for analysis of the Prostate Cancer Prevention Trial.

Authors: Yael C Cohen; Kenneth S Liu; Norman L Heyden; Alexandra D Carides; Keaven M Anderson; Anastasia G Daifotis; Peter H Gann
Journal: J Natl Cancer Inst Date: 2007-09-11 Impact factor: 13.506

11 in total

Review 1. Prostate cancer: from the pathophysiologic implications of some genetic risk factors to translation in personalized cancer treatments.

Authors: C R Balistreri; G Candore; D Lio; G Carruba
Journal: Cancer Gene Ther Date: 2014-01-10 Impact factor: 5.987

Review 2. Synthetic DNA approach to cytomegalovirus vaccine/immune therapy.

Authors: Stephan J Wu; Daniel O Villarreal; Devon J Shedlock; David B Weiner
Journal: Adv Exp Med Biol Date: 2015 Impact factor: 2.622

3. Silybin Prevents Prostate Cancer by Inhibited the ALDH1A1 Expression in the Retinol Metabolism Pathway.

Authors: Ying Jiang; Hanbing Song; Ling Jiang; Yu Qiao; Dan Yang; Donghua Wang; Ji Li
Journal: Front Cell Dev Biol Date: 2020-08-31

4. Polyphenols from the mangosteen (Garcinia mangostana) fruit for breast and prostate cancer.

Authors: Gongbo Li; Stacey Thomas; Jeremy J Johnson
Journal: Front Pharmacol Date: 2013-06-26 Impact factor: 5.810

5. Partial response of liver metastases treated with abiraterone in castration-resistant prostate cancer: A case report.

Authors: Ilaria Marech; Angelo Vacca; Nicola Sivestris; Antonio Gnoni; Vito Lorusso
Journal: Oncol Lett Date: 2013-03-29 Impact factor: 2.967

6. Correlations Between Intratumoral Interstitial Fibrillary Network and Vascular Network in Gleason Patterns of Prostate Adenocarcinoma.

Authors: R M Pleșea; M S Șerbănescu; D O Alexandru; V Ciovică; A Stoiculescu; O T Pop; C Simionescu; I E Pleșea
Journal: Curr Health Sci J Date: 2015-12-22

7. Identifying quality of life indicators to improve outpatient pharmacy services for prostate cancer patients: a comparison between Brazilian and British experiences.

Authors: Harindra Patel; Patrícia Melo Aguiar; Adalberto Pessoa; Sílvia Storpirtis; Paul F Long
Journal: Int Braz J Urol Date: 2019 May-Jun Impact factor: 1.541